Similar Papers

Paper Title
Journal
Date
Author
Medicinal chemistry strategies for the development of phosphodiesterase 10A (PDE10A) inhibitors - An update of recent progress
Harsh S Amin ... Palak K Parikh
European Journal of Medicinal Chemistry | VOL. 214
Harsh S Amin, et. al.Harsh S Amin ... Palak K Parikh
09 Jan 2021
PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth.
Si Chen ... Han Yu
Circulation research | VOL. 133
Si Chen, et. al.Si Chen ... Han Yu
26 May 2023
Abstract 1213: PDE10A as a novel target to suppress Wnt/β-catenin signaling and other oncogenic pathways in ovarian cancer
Rebecca M Barber ... Steve Mcclellan
Cancer Research | VOL. 81
Rebecca M Barber, et. al.Rebecca M Barber ... Steve Mcclellan
01 Jul 2021
TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms.
Kazunori Suzuki ... Akina Harada
Neuropsychopharmacology | VOL. 41
Kazunori Suzuki, et. al.Kazunori Suzuki ... Akina Harada
05 Feb 2016
View more papers

More From: The Scientific Notes of the Pavlov University

Paper Title
Journal
Date
Author
-
-
The Scientific Notes of the Pavlov University | VOL. 31
--
17 Dec 2024
Risk factors and prevalence of strokes in patients with multiple sclerosis
Yu M Kiryanov ... N A Totolyan
The Scientific Notes of the Pavlov University | VOL. 31
Yu M Kiryanov, et. al.Yu M Kiryanov ... N A Totolyan
03 Nov 2024
Surgical management of delivery with placenta accreta spectrum from the perspective of perinatal obstetrics
A Yu Ralnikova ... O L Molchanov
The Scientific Notes of the Pavlov University | VOL. 31
A Yu Ralnikova, et. al.A Yu Ralnikova ... O L Molchanov
03 Nov 2024
Analysis of the quality of life in patients with multiple sclerosis within 3 years after high-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation
A Yu Polushin ... A D Kulagin
The Scientific Notes of the Pavlov University | VOL. 31
A Yu Polushin, et. al.A Yu Polushin ... A D Kulagin
03 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.